Drug therapy combined with an LVAD can reverse heart failure
This article has no abstract so we have provided the first paragraph of the full text.
Use of a left ventricular assist device (LVAD) can reverse left ventricular remodeling in patients with heart failure, but recovery sufficient to permit explantation has so far been achieved in only a small number of patients. To increase the recovery rate, researchers in the UK have combined implantation of an LVAD with pharmacologic therapy known to assist reverse remodeling.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
